How often do patients with psychosis fail to adhere to treatment programmes? A systematic review
- PMID: 14580069
- DOI: 10.1017/s0033291703008328
How often do patients with psychosis fail to adhere to treatment programmes? A systematic review
Abstract
Background: Studies that assess the rates of psychotic patients who fail to adhere to treatment programmes have generated heterogeneous results, with estimates ranging from 24 to 90%. This paper presents findings from a systematic review on adherence to treatment by patients with psychosis. Its purpose is to provide an overall estimate of treatment non-adherence in community psychiatric services, and to analyse and study patient characteristics explaining the between-study heterogeneity in rates of non-adherence.
Method: A systematic review of published studies that report rates of non-adherence with medication and scheduled appointments by psychotic patients in community settings has been undertaken.
Results: A total of 103 studies were included in this systematic review. Eighty-six of these studies were suitable for data re-analysis. The overall weighted mean rate of non-adherence, calculated in a sample of 23 796 patients, was 25.78%. A linear regression analysis of non-adherence rates on background characteristics showed that sample size was negatively associated with non-adherence rates, while first-contact cases and low-adherence cases, in comparison with ongoing cases, were associated with higher non-adherence rates. Factors associated with poor compliance included: lack of insight; positive symptoms; younger age; male gender; history of substance abuse; unemployment; and low social functioning.
Conclusions: Approximately one in four patients with psychosis fails to adhere with treatment programmes. Preventive evidence-based clinical interventions should be routinely implemented in community settings to reduce patient non-adherence.
Similar articles
-
Home treatment for mental health problems: a systematic review.Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150. Health Technol Assess. 2001. PMID: 11532236
-
Sertindole for schizophrenia.Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2. Cochrane Database Syst Rev. 2005. PMID: 16034864 Free PMC article.
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
Psychological and/or educational interventions for the prevention of depression in children and adolescents.Cochrane Database Syst Rev. 2004;(1):CD003380. doi: 10.1002/14651858.CD003380.pub2. Cochrane Database Syst Rev. 2004. Update in: Cochrane Database Syst Rev. 2011 Dec 07;(12):CD003380. doi: 10.1002/14651858.CD003380.pub3. PMID: 14974014 Updated.
-
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340. Health Technol Assess. 2006. PMID: 16959170
Cited by
-
First-episode schizophrenia: a focus on pharmacological treatment and safety considerations.Drugs. 2005;65(8):1113-38. doi: 10.2165/00003495-200565080-00006. Drugs. 2005. PMID: 15907146 Review.
-
Determining engagement in services for high-need individuals with serious mental illness.Adm Policy Ment Health. 2014 Sep;41(5):588-97. doi: 10.1007/s10488-013-0497-1. Adm Policy Ment Health. 2014. PMID: 23636712 Free PMC article.
-
Families and medication use and adherence among Latinos with schizophrenia.J Ment Health. 2017 Feb;26(1):14-20. doi: 10.1080/09638237.2016.1222061. Epub 2016 Oct 1. J Ment Health. 2017. PMID: 27690706 Free PMC article.
-
The clinician-patient working alliance: Is it a significant predictor of psychiatric medication adherence in a sample of recently released parolees?J Forens Psychiatry Psychol. 2018;29(5):782-793. doi: 10.1080/14789949.2018.1477976. Epub 2018 May 23. J Forens Psychiatry Psychol. 2018. PMID: 30524208 Free PMC article.
-
Current State of Fluid Lipid Biomarkers for Personalized Diagnostics and Therapeutics in Schizophrenia Spectrum Disorders and Related Psychoses: A Narrative Review.Front Psychiatry. 2022 May 27;13:885904. doi: 10.3389/fpsyt.2022.885904. eCollection 2022. Front Psychiatry. 2022. PMID: 35711577 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical